Janet Dorling
Corporate Officer/Principal bei GILEAD SCIENCES, INC.
Aktive Positionen von Janet Dorling
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2020 | - |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Direktor/Vorstandsmitglied | 01.02.2023 | - |
Karriereverlauf von Janet Dorling
Ehemalige bekannte Positionen von Janet Dorling
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYMABAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.04.2021 | 22.03.2024 |
CYMABAY THERAPEUTICS, INC. | Corporate Officer/Principal | 05.08.2019 | 01.12.2019 |
ACHAOGEN | Corporate Officer/Principal | 27.02.2017 | 30.06.2019 |
ROCHE HOLDING AG | Corporate Officer/Principal | 01.01.2015 | 01.01.2017 |
Ausbildung von Janet Dorling
Duke University | Graduate Degree |
University of California, Berkeley | Masters Business Admin |
Haas School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Schweiz | 2 |
Belgien | 2 |
Operativ
Corporate Officer/Principal | 4 |
Masters Business Admin | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
ROCHE HOLDING AG | Health Technology |
Private Unternehmen | 3 |
---|---|
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Gilead Sciences Belgium BV
Gilead Sciences Belgium BV Medical DistributorsDistribution Services Gilead Sciences Belgium BV is a Belgian company that was founded in 2006. The private company is based in Machelen, Belgium. The company provides a portal for healthcare professionals under the name Gilead Sciences. | Distribution Services |
- Börse
- Insiders
- Janet Dorling
- Erfahrung